An overview of pim kinase as a target in multiple myeloma
Abstract Multiple myeloma (MM) is the second common hematologic malignancy manifesting as a clonal proliferation of plasma cells in the bone marrow. In recent years, high expression and activity of pim kinase have been found to be associated with both the progression and prognosis of a significant p...
Main Authors: | Zhaoyun Liu, Yunhe Zhang, Yixuan Guo, Hao Wang, Rong Fu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-05-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.5797 |
Similar Items
-
Pim-2 Kinase Regulates Energy Metabolism in Multiple Myeloma
by: Zhaoyun Liu, et al.
Published: (2022-12-01) -
PIM Kinases in Multiple Myeloma
by: Jian Wu, et al.
Published: (2021-08-01) -
Protein Translation Inhibition is Involved in the Activity of the Pan-PIM Kinase Inhibitor PIM447 in Combination with Pomalidomide-Dexamethasone in Multiple Myeloma
by: Teresa Paíno, et al.
Published: (2020-09-01) -
Aberrant metabolic processes promote the immunosuppressive microenvironment in multiple myeloma
by: Junqiang Lv, et al.
Published: (2022-11-01) -
Myeloma–Bone Interaction: A Vicious Cycle via TAK1–PIM2 Signaling
by: Takeshi Harada, et al.
Published: (2021-09-01)